Shopping Cart
- Remove All
Your shopping cart is currently empty
ABT-080 (VML 530), a leukotriene synthesis inhibitor, is used potentially for treatment of asthma.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $50 | In Stock | |
| 10 mg | $75 | In Stock | |
| 25 mg | $128 | In Stock | |
| 50 mg | $192 | In Stock | |
| 100 mg | $287 | In Stock | |
| 200 mg | $431 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $83 | In Stock |
| Description | ABT-080 (VML 530), a leukotriene synthesis inhibitor, is used potentially for treatment of asthma. |
| In vitro | ABT-080 Inhibits calcium ionophore (A-23187)-stimulated LTB4 formation in human neutrophils with IC50 of 20nM. ABT-080 inhibits LTB4 production with an IC50 of 13000nM in a calcium ionophore-stimulated human whole blood assay. |
| Synonyms | VML-530, VML530, VML 530, ABT080 |
| Molecular Weight | 590.64 |
| Formula | C37H31N2NaO4 |
| Cas No. | 189498-57-5 |
| Smiles | [Na+].CC(CCC([O-])=O)(c1ccc(OCc2ccc3ccccc3n2)cc1)c1ccc(OCc2ccc3ccccc3n2)cc1 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (84.65 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.